← Leaderboards
Victoria Perepelitsa Belancio
Southeast Louisiana Veterans Health Care
$4,068,025
Attributed
$4,256,463
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $749.2K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,256,463 · 6
VA$0 · 1
By mechanism
R01$2,035,015 · 1
P30$924,160 · 1
R21$753,126 · 2
K01$504,162 · 1
R13$40,000 · 1
I01$0 · 1
Top collaborators
- Astrid M Engel2 shared
Others in their field
Top investigators on “Elements”
- Richard K. Wilson · Washington University$332,639,077
- Barton F Haynes · Duke University$292,876,624
- Eric S Lander · Whitehead Institute For Biomedical Res$232,780,693
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$186,492,164
- David W Simpson · University Of Southern California$143,628,960
Research focus
ElementsDna DamageGenomeGenomic InstabilityTissuesGeneticReportingMutationDesignGenomicsLeadVariantCellsHuman GenomeLongevitySourceSomatic CellTissue CultureMalignant NeoplasmsAgingRetrotransposonEndonucleaseHuman TissueMutant
Grant awards (23)
Pilot Projects Program$231,040
P30 · FY2025 · GM · contact PI
Polymorphic L1 transposons as a Genetic Variable Distinguishing Aggressive from Indolent Prostate Cancer$0
I01 · FY2025 · VA · contact PI
Pilot Projects Program$231,040
P30 · FY2024 · GM · contact PI
Polymorphic L1 transposons as a Genetic Variable Distinguishing Aggressive from Indolent Prostate Cancer$0
I01 · FY2024 · VA · contact PI
Pilot Projects Program$231,040
P30 · FY2023 · GM · contact PI
The impact of LINE-1 retrotransposons on life span, SASP, and telomeres in vivo$334,400
R01 · FY2022 · AG · contact PI
Pilot Projects Program$231,040
P30 · FY2022 · GM · contact PI
Polymorphic L1 transposons as a Genetic Variable Distinguishing Aggressive from Indolent Prostate Cancer$0
I01 · FY2022 · VA · contact PI
A Forgotten Connection: Retrotransposon contribution to Alzheimer's Disease$374,800
R01 · FY2021 · AG · contact PI
The impact of LINE-1 retrotransposons on life span, SASP, and telomeres in vivo$334,400
R01 · FY2021 · AG · contact PI
FASEB's Mobile DNA: Evolution, Diversity, and Impact Conference.$40,000
R13 · FY2021 · AG · contact PI
The impact of LINE-1 retrotransposons on life span, SASP, and telomeres in vivo$334,308
R01 · FY2020 · AG · contact PI
The impact of LINE-1 retrotransposons on life span, SASP, and telomeres in vivo$333,117
R01 · FY2019 · AG · contact PI
Cadmium exposure promotes genomic instability by stimulating L1 retrotransposition in vivo$188,751
R21 · FY2019 · ES · contact PI
The impact of LINE-1 retrotransposons on life span, SASP, and telomeres in vivo$323,990
R01 · FY2018 · AG · contact PI
Cadmium exposure promotes genomic instability by stimulating L1 retrotransposition in vivo$188,125
R21 · FY2018 · ES · contact PI
The impact of advanced parental age on genomic instability in offspring associated with retrotransposon-induced DNA damage$188,125
R21 · FY2018 · AG · contact PI
The impact of advanced parental age on genomic instability in offspring associated with retrotransposon-induced DNA damage$188,125
R21 · FY2017 · AG · contact PI
L 1 element as an inrinsic factor of mammalian aging$114,397
K01 · FY2012 · AG · contact PI
L 1 element as an inrinsic factor of mammalian aging$114,397
K01 · FY2011 · AG · contact PI
L 1 element as an inrinsic factor of mammalian aging$93,874
K01 · FY2010 · AG · contact PI
L 1 element as an inrinsic factor of mammalian aging$91,769
K01 · FY2009 · AG · contact PI
L 1 element as an inrinsic factor of mammalian aging$89,725
K01 · FY2008 · AG · contact PI